Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 June 2021 | Story Ruan Bruwer | Photo Johan Roux
Ox Nche during his playing days for the Shimlas in 2015. He might make a return to the Springbok team after three years.

It will be a small reunion for a couple of ex-Shimlas when almost the full Springbok squad gathers at Shimla Park this week.

This will then be the third week of training, but for the first time with the majority of the 46 squad members, as most players have finished their provincial and club commitments. They are preparing in Bloemfontein for the upcoming test season, which includes a test series against the British and Irish Lions.

Ox Nche (Shimlas 2015 and 2016) and Coenie Oosthuizen (2008) are members of the squad from which a Springbok and a South African A team will be chosen.

Both have represented the Springboks before – Nche in a single test in 2018, and Oosthuizen in 30 tests between 2012 and 2017.

Apart from the two players, there are three former University of the Free State students in the coaching staff. Rugby World Cup winning coach, Rassie Erasmus, is now the director of rugby at the South African Rugby Union, while former Bok defence coach (in 2018 and 2019), Jacques Nienaber, was promoted to head coach last year. The Springboks have not played a test under him yet.

The two first worked together in the Shimlas U20 team, where Erasmus was the captain and Nienaber the physio. Erasmus wore the famous blue jersey between 1993 and 1995. Daan Human, a former Shimla (1999-2000) and Shimla assistant coach, was appointed as the scrum coach of the national team last year.

Nche, a double Varsity Cup winner with the Young Guns in 2014 and the Shimlas in 2015, is strongly in the race for a place in the Springbok team.

Deon Davids, assistant coach of the Boks, recently had high praise for Nche.
“It is well-known that Ox is a quality player. Ox has been a consistent performer. His presence in the camp is an asset,” Davids said.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept